Page 347 - “O‘ZBEKISTON – 2030 STRATEGIYASI: AMALGA OSHIRILAYOTGAN ISLOHOTLAR TAHLILI, MUAMMOLAR VA YECHIMLAR”

datasets. ML algorithms (e.g., neural networks, decision trees) identify patterns and
deliver personalized recommendations [3, 4]. NLP extracts structured information
from clinical notes and electronic health records (EHRs), while DL, particularly
convolutional neural networks (CNNs), excels in image-based diagnostics. Esteva et
al. [6] demonstrated dermatologist-level accuracy in skin cancer classification using
CNNs [3, 5].
Despite progress, challenges persist—data heterogeneity, algorithmic opacity,
ethical risks, and limited clinician readiness. This research examines the impact,
limitations, and ethical implications of AI-CDSS, aiming to:
1. Evaluate AI’s effect on diagnostic and therapeutic accuracy;
2. Identify ethical and technical barriers;
3. Propose a framework for secure, interpretable CDSS deployment.
Ultimately, the study advocates responsible AI integration—systems designed
to support, not replace, clinical expertise.

METHODOLOGY
This research employed a mixed-method approach combining systematic
literature review, comparative performance analysis, and interpretive evaluation of
clinical AI applications. The study design adheres to the PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) framework to ensure
methodological transparency and reproducibility.

1. Data Sources and Selection Criteria
The primary data sources include peer-reviewed journals, institutional reports,
and validated case studies published between 2018 and 2024. Databases such as
PubMed, Scopus, ScienceDirect, and the WHO Global Health Observatory were
queried using keywords including Artificial Intelligence, Clinical Decision Support
Systems, Machine Learning in Healthcare, and Diagnostic Accuracy. Only studies
reporting empirical results, statistical evaluation, or clinical validation were included.
Exclusion criteria comprised preprints, non-peer-reviewed materials, and studies
lacking quantitative performance metrics.

2. Analytical Framework
The methodology integrates both qualitative synthesis and quantitative
benchmarking:
• Descriptive Analysis: Identification of key AI applications in CDSS, categorized
by domain (diagnostics, prediction, therapy planning).
• Comparative Benchmarking: Evaluation of performance metrics such as
sensitivity, specificity, and accuracy across leading AI systems, including
Google Health AI, IBM Watson for Oncology, and DeepMind Retinopathy
Detection .
• Statistical Visualization: Data were analyzed using statistical tools to produce
comparative tables and graphical models illustrating accuracy differentials,
error reduction, and predictive gains.
Interpretability and Ethical Evaluation: Examination of model transparency,
data governance, and fairness principles following WHO (2021) ethical guidelines.
344

V SHO‘BA:

Raqamli transformatsiya va ilg‘or boshqaruv tizimlarini joriy etish samaradorligi

https://www.asr-conference.com